BackAllergy Therapeutics plc Overview

Allergy Therapeutics plc Total Liabilities

Track Allergy Therapeutics plc's total liabilities ($67M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$66.75M
↓ 16.68% YoYΔ $-13.37M vs prior year quarter

Peer trimmed avg / median

Loading

Allergy Therapeutics plc Total Liabilities History

Loading

Allergy Therapeutics plc vs. peers: Total Liabilities Comparison

Loading

Allergy Therapeutics plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Allergy Therapeutics plc (AGYTF) FAQ

Allergy Therapeutics plc (AGYTF) currently reports a total liabilities of $67M as of December 2025. That compares with $80M in the prior-year period — down 16.7% year over year. Use the charts on this page to explore Allergy Therapeutics plc's total liabilities history and peer comparisons.

Allergy Therapeutics plc's total liabilities decreased from $80M to $67M — a 16.7% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Allergy Therapeutics plc reported $67M in total liabilities as of December 2025. That compares with $80M in the prior-year period — down 16.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $67M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allergy Therapeutics plc, and consider following AGYTF for alerts when major investors trade the stock.